The MDS Non-Motor Rating Scale (MDS-NMS): A new measure for non-motor Parkinson’s disease
Available starting August 14, 2020
This accredited webinar is provided free of cost to all members and non-members.
Live Q&A Session
September 1, 2020 at 7:00am CDT
K. Ray Chaudhuri, MD, DSc, FRCP
Pablo Martinez-Martin, MD, PhD
Anette Schrag, FRCP, PhD
Daniel Weintraub, MD
The MDS-NMS is a state of the art and up to date revision of the Non-Motor Symptoms Scale (NMSS), a widely used scale in the field of Movement Disorders clinical practice and trials since 2007. The MDS-NMS was developed to improve and refine the assessment of non-motor symptoms in Parkinson’s disease (PD) and more fully cover aspects of non-motor Parkinson’s symptoms which have evolved over the last 10 years. This rater-completed assessment measures frequency and severity of 13 non-motor domains (as opposed to nine domains in the original NMSS), over 52 items and covers a range of key non-motor symptoms both PD and treatment related, and in greater depth, compared with the NMSS. The scale also has a new MDS-NMS Non-Motor Fluctuations (NMF) Subscale to assess changes in non-motor symptoms in relation to the timing of anti-parkinsonian medications across 8 domains.
The purpose of this webinar is to provide an overview of the new scale, demonstrate how it compares to the original NMSS, and present information that clinicians and clinical trial raters should have to administer and use the instrument.
This course is intended for clinicians that are treating Parkinson’s disease patients, clinical trial representatives and raters from all health care professional backgrounds.
- Discuss key characteristics of the MDS-NMS including, but not limited to, the domains measured by the MDS-NMS, time to administer and information about the reliability and reproducibility of the scale
- Understand the differences between the MDS-NMS and the original NMSS
- Understand the populations and disease conditions for which the scale can be used
- Understand how to administer and score the MDS-NMS
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement
The International Parkinson and Movement Disorder Society designates this activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation.
Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.
Content Validity Statement
All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.
Faculty Financial Disclosure Information
All individuals in control of content for this webinar are required to disclose all relevant financial relationships with commercial interests as defined by the ACCME. Disclosure information is available here.